Gastric Volume in Diabetic Patients Undergoing Staged Bilateral Total Knee Arthroplasty
NCT ID: NCT04815070
Last Updated: 2022-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2021-03-29
2022-03-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the previous study, evidence of increased pain was reported in patients undergoing staged bilateral total knee arthroplasty, in whom the second operated knee had greater sensitivity (tertiary hyperalgesia) due to the surgical injury to the first operated knee.
In the present study, we will evaluate the effect of old age, diabetes, surgical stress, pain, and the use of analgesics on the residual gastric volume in elderly patients undergoing staged-bilateral total knee arthroplasty.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Value of Ultrasound Measurement of Stomach Diameter in Predicting Postoperative Nausea/Vomiting
NCT07063069
Estimation of Preoperative Gastric Volume Using Ultrasound
NCT03155776
Ultrasound Assessment of Gastric Content and Volume
NCT02810977
Dumping Syndrome and Quality of Life After Vagus Nerve-preserving Distal Gastrectomy
NCT03880747
Ultrasound Estimation of Gastric Volumes in Patients With Previous Gastric Sleeve
NCT06533046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic
A group of diabetic patients who have fasted for at least 8 hours undergoing staged bilateral total knee arthroplasty.
Ultrasonic measurement of antral area
Ultrasound exam is done before the induction of spinal anesthesia. Three consecutive measurements of the anteroposterior (AP) and cranio-caudal (CC) diameters are performed.
The cross-sectional area (CSA) of antrum is shown by the following formula: CSA = AP x CC x ㅠ/4.
Antral area will correspond to the average of the three measures.
Non-Diabetic
A group of non-diabetic patients who have fasted for at least 8 hours undergoing staged bilateral total knee arthroplasty.
Ultrasonic measurement of antral area
Ultrasound exam is done before the induction of spinal anesthesia. Three consecutive measurements of the anteroposterior (AP) and cranio-caudal (CC) diameters are performed.
The cross-sectional area (CSA) of antrum is shown by the following formula: CSA = AP x CC x ㅠ/4.
Antral area will correspond to the average of the three measures.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasonic measurement of antral area
Ultrasound exam is done before the induction of spinal anesthesia. Three consecutive measurements of the anteroposterior (AP) and cranio-caudal (CC) diameters are performed.
The cross-sectional area (CSA) of antrum is shown by the following formula: CSA = AP x CC x ㅠ/4.
Antral area will correspond to the average of the three measures.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anestheiologist physical status classification 1, 2, and 3
* Body mass index \< 35 kg/cm2
Exclusion Criteria
* Achalasia
65 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyo-Seok Na
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-2103/673-307
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.